Aeolus Pharmaceuticals, Inc. Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2015 | 3.11M | Sales 2016 | 2.08M | Capitalization | 28.9M |
---|---|---|---|---|---|
Net income 2015 | -2M | Net income 2016 | -3M | EV / Sales 2015 | 10.8 x |
Net Debt 2015 | 908K | Net cash position 2016 | 3.16M | EV / Sales 2016 | 12.4 x |
P/E ratio 2015 |
-12
x | P/E ratio 2016 |
-4.67
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
John McManus
CEO | Chief Executive Officer | 60 | 05-05-31 |
David Cavalier
CHM | Chairman | 54 | 04-04-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Cavalier
CHM | Chairman | 54 | 04-04-29 |
Jeffrey Scott
BRD | Director/Board Member | 67 | 13-05-07 |
John Clerici
BRD | Director/Board Member | 54 | 13-05-07 |
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |